Cancer accounts for millions of deaths every year, and the burden of this disease is
striking - testing our families, health-care systems, economies, and our scientists.
In recent years, the outstanding work of researchers and vast improvements in
technology has led to remarkable strides in progress. We are now able to prevent
at least one third of cancers and have adapted routine-screening techniques
for early detection and effective treatment. Our ability to treat and manage this
shape-shifting disease has also transformed, as we have developed sophisticated
therapies and adopted more tailored approaches. As a result, survival rates are
reaching new highs each year, and the outlook for those affected is improving.
However, there are still areas that require our attention.
Unfortunately, inequalities are well known in the field. In areas where resources are
scarce and outreach is limited, cancer patients do not have access to educational
programs, timely diagnosis and quality treatment. Significant knowledge-gaps also
exist within cancer research, with many minority populations being underrepresented
in clinical trials and underreported within the literature. Considering that scientific
progress relies on the publication and dissemination of research, the lack of access
to primary literature also falters, with many breakthroughs hidden behind paywalls.
This not only affects clinicians and researchers, reinforcing a negative feedback-loop
for researchers already struggling to obtain sufficient funding, but inhibits the next
generation of curious students.
Each year, February 4th marks World Cancer Day; a movement dedicated to
channeling awareness, education, and unity into collective initiatives and global
action against one of medicine’s toughest challenges. The theme of 2021, “I Am and
I Will” was one of power, encouraging commitment and togetherness; a sentiment
resonating in today’s turbulent world. In honor of this day, Frontiers in Oncology
has invited a retrospective of articles from our Specialty Chief Editors, highlighting
current, international challenges in their corresponding fields of oncology. Our goal
is to empower continuous discussion between communities and across borders,
drawing attention to the disparities faced in the field. Our achievements should be
shared to maximize impact and facilitate opportunities worldwide. We know that
cancer does not discriminate. So, neither should we.
We also take this opportunity to thank the wider community for their continued
efforts in allowing for accelerated scientific developments, and most importantly
for working with us on our mission to make science open.
Nicola Faramarzi, PhD
On behalf of the Frontiers in Oncology Editorial Office